<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04024345</url>
  </required_header>
  <id_info>
    <org_study_id>Psy-FPC</org_study_id>
    <nct_id>NCT04024345</nct_id>
  </id_info>
  <brief_title>The Emotional Impact of Surveillance for Pancreatic Cancer</brief_title>
  <official_title>Surveillance Program in High-risk Individuals for Pancreatic Cancer: Prospective Analysis of the Emotional Impact</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria Integrata Verona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria Integrata Verona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Due to its rarity a population screening program for pancreatic cancer is not possible. For
      this reason, considering background data on genetic predisposition and familiarity for this
      lethal tumor, efforts have been pushed to build up surveillance programs for subjects at
      high-risk of pancreatic cancer, due to familiarity and/or genetic predisposition. These
      programs are based on radiological examinations (such as MRI or endoultrasonography) and
      laboratory tests. However, little is known about the psychological burden of these programs.
      Only a handful of studies investigated, in various ways, how the participation in
      surveillance programs for pancreatic cancer may burden the psychological status, with a
      consequent possible impairment of the psychological wellbeing, and a higher risk of withdraw
      from the surveillance program itself. The aim of this study was to assess the psychological
      and emotional impact in high-risk individuals participating in a surveillance program for
      pancreatic cancer due to familiarity and/or to genetic predisposition, using specific
      psychological tools, such as multiple psychological questionnaires, investigating different
      functioning areas, administered by a clinical psychologist.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Barratt Simplified Measure of Social Status</measure>
    <time_frame>Baseline</time_frame>
    <description>Evaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Barratt Simplified Measure of Social Status</measure>
    <time_frame>2-years</time_frame>
    <description>Evaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Global Assessment of Functioning scale</measure>
    <time_frame>Baseline</time_frame>
    <description>measure overall levels of functionality of an individual</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Global Assessment of Functioning scale</measure>
    <time_frame>2-years</time_frame>
    <description>measure overall levels of functionality of an individual</description>
  </primary_outcome>
  <primary_outcome>
    <measure>General Self-Efficacy Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-report scale correlated to emotion, optimism, work</description>
  </primary_outcome>
  <primary_outcome>
    <measure>General Self-Efficacy Scale</measure>
    <time_frame>2-years</time_frame>
    <description>Self-report scale correlated to emotion, optimism, work</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Perceived Stress Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessment of the perceived stress</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Perceived Stress Scale</measure>
    <time_frame>2-year</time_frame>
    <description>Assessment of the perceived stress</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coping Orientation to Problems Experienced</measure>
    <time_frame>Baseline</time_frame>
    <description>evaluation of the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coping Orientation to Problems Experienced</measure>
    <time_frame>2-years</time_frame>
    <description>evaluation of the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Multidimensional Scale of Perceived Social Support</measure>
    <time_frame>Baseline</time_frame>
    <description>to explore the subject's social support system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Multidimensional Scale of Perceived Social Support</measure>
    <time_frame>2-years</time_frame>
    <description>to explore the subject's social support system</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Psychological Distress</condition>
  <arm_group>
    <arm_group_label>Psychometric assessment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arms to whom the psychometric assessment will be administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Barratt Simplified Measure of Social Status (BSMSS)</intervention_name>
    <description>Questionnaire that evaluates cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)</description>
    <arm_group_label>Psychometric assessment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Global Assessment of Functioning scale (GAF)</intervention_name>
    <description>Used to measure overall levels of functionality of an individual</description>
    <arm_group_label>Psychometric assessment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>General Self-Efficacy Scale (GSES)</intervention_name>
    <description>Psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life</description>
    <arm_group_label>Psychometric assessment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Perceived Stress Scale (PSS)</intervention_name>
    <description>To assess the perceived stress</description>
    <arm_group_label>Psychometric assessment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Coping Orientation to Problems Experienced (Brief COPE),</intervention_name>
    <description>It evaluates the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations</description>
    <arm_group_label>Psychometric assessment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Multidimensional Scale of Perceived Social Support (MSPSS)</intervention_name>
    <description>to explore the subject's social support system</description>
    <arm_group_label>Psychometric assessment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being enrolled in the Institutional surveillance program for pancreatic cancer

          -  Ability to understand the details and implications of a study protocol.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Verona</name>
      <address>
        <city>Verona</city>
        <state>VR</state>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Maheu C, Vodermaier A, Rothenmund H, Gallinger S, Ardiles P, Semotiuk K, Holter S, Thayalan S, Esplen MJ. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam Cancer. 2010 Dec;9(4):617-24. doi: 10.1007/s10689-010-9354-5.</citation>
    <PMID>20623197</PMID>
  </results_reference>
  <results_reference>
    <citation>Konings IC, Harinck F, Kuenen MA, Sidharta GN, Kieffer JM, Aalfs CM, Poley JW, Smets EM, Wagner A, van Rens A, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ, Bleiker EM; Dutch research group on pancreatic cancer surveillance in high-risk individuals. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer. 2017 Jan;16(1):143-151. doi: 10.1007/s10689-016-9930-4.</citation>
    <PMID>27629874</PMID>
  </results_reference>
  <results_reference>
    <citation>Harinck F, Nagtegaal T, Kluijt I, Aalfs C, Smets E, Poley JW, Wagner A, van Hooft J, Fockens P, Bruno M, Bleiker EM. Feasibility of a pancreatic cancer surveillance program from a psychological point of view. Genet Med. 2011 Dec;13(12):1015-24. doi: 10.1097/GIM.0b013e31822934f5.</citation>
    <PMID>21857231</PMID>
  </results_reference>
  <results_reference>
    <citation>Konings IC, Sidharta GN, Harinck F, Aalfs CM, Poley JW, Kieffer JM, Kuenen MA, Smets EM, Wagner A, van Hooft JE, van Rens A, Fockens P, Bruno MJ, Bleiker EM. Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology. 2016 Aug;25(8):971-8. doi: 10.1002/pon.4047. Epub 2015 Dec 3.</citation>
    <PMID>26632416</PMID>
  </results_reference>
  <results_reference>
    <citation>Cazacu IM, Luzuriaga Chavez AA, Saftoiu A, Bhutani MS. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: A systematic review. Endosc Ultrasound. 2019 Jan-Feb;8(1):17-24. doi: 10.4103/eus.eus_25_18. Review.</citation>
    <PMID>30246710</PMID>
  </results_reference>
  <results_reference>
    <citation>Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E, Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry. Am J Gastroenterol. 2019 Apr;114(4):665-670. doi: 10.1038/s41395-018-0414-z.</citation>
    <PMID>30538291</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 10, 2019</study_first_submitted>
  <study_first_submitted_qc>July 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2019</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria Integrata Verona</investigator_affiliation>
    <investigator_full_name>Erica Secchettin</investigator_full_name>
    <investigator_title>Institutional Project Manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

